Revolutionary Cedars-Sinai AI Technology
Artificial intelligence has made a breakthrough in cardiac diagnostics at the Smidt Heart Institute. Researchers have successfully trained an AI program to identify early signs of tricuspid valve disease by analyzing…
California-based Capstan Medical, maker of robotic-enabled tools for heart valve disease, closed an oversubscribed $110 million Series C round led by Eclipse. Existing investors Intuitive Ventures, Yu Galaxy, and new investor Gideon Strategic Partners, participated…
Continue Reading
What You Should Know:
– Capstan Medical, a medical technology company developing innovative solutions for heart valve disease secures $110M in a Series C funding round led by Eclipse with participation from existing investors Yu…
Continue Reading
ASX-listed Echo IQ has obtained regulatory approval in the United States for its AI-driven solution that supports structural heart disease diagnosis.WHAT IT’S ABOUT
Two years since coming to the US, the company has now received…
The convergence of computational modeling and pediatric cardiology heralds a new era of precision medicine. By simulating heart valve shape, identifying weak spots, and analyzing blood flow dynamics, these models offer predictive insights into…
Continue Reading
